|
End-of-day quote
Ho Chi Minh S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 19,600.00 VND | -0.51% |
|
-1.75% | -4.45% |
| 09-11 | OPC Pharmaceutical Joint Stock Company Announces Change In Certificate Of Business Registration | CI |
| 08-17 | Opc Pharmaceutical Joint Stock Company Terminates Operations of Tien Giang Branch | CI |
Company Valuation: OPC Pharmaceutical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,581,348 | 1,520,220 | 1,761,400 | 1,537,221 | 1,601,272 | 1,537,221 |
| Change | - | -3.87% | 15.86% | -12.73% | 4.17% | -4% |
| Enterprise Value (EV) 1 | 1,568,096 | 1,373,409 | 1,446,194 | 1,215,860 | 1,353,985 | 1,218,052 |
| Change | - | -12.42% | 5.3% | -15.93% | 11.36% | -10.04% |
| P/E | 15x | 12.1x | 13.8x | 14.7x | 17.6x | 15.6x |
| PBR | 2.45x | 2.23x | 2.18x | 1.87x | 1.97x | 1.69x |
| PEG | - | 0.6x | 8.41x | -0.8x | -1.3x | 1.89x |
| Capitalization / Revenue | 1.64x | 1.35x | 1.5x | 1.53x | 1.65x | 1.37x |
| EV / Revenue | 1.62x | 1.22x | 1.23x | 1.21x | 1.4x | 1.08x |
| EV / EBITDA | 9.92x | 7.26x | 7.18x | 7.19x | 8.64x | 7.92x |
| EV / EBIT | 11.5x | 8.24x | 8.1x | 8.32x | 10.1x | 9.21x |
| EV / FCF | 16x | 6.71x | 9.7x | 12.8x | 106x | 21.3x |
| FCF Yield | 6.26% | 14.9% | 10.3% | 7.78% | 0.94% | 4.7% |
| Dividend per Share 2 | 1,064 | - | 1,282 | 1,282 | - | 683.8 |
| Rate of return | 5.04% | - | 5.45% | 6.25% | - | 3.33% |
| EPS 2 | 1,408 | 1,682 | 1,709 | 1,397 | 1,214 | 1,314 |
| Distribution rate | 75.6% | - | 75% | 91.8% | - | 52% |
| Net sales 1 | 965,591 | 1,123,728 | 1,171,614 | 1,004,887 | 968,576 | 1,122,987 |
| EBITDA 1 | 158,152 | 189,215 | 201,454 | 169,015 | 156,652 | 153,844 |
| EBIT 1 | 136,411 | 166,713 | 178,636 | 146,120 | 134,434 | 132,289 |
| Net income 1 | 105,791 | 126,377 | 142,128 | 122,234 | 107,060 | 115,881 |
| Net Debt 1 | -13,252 | -146,811 | -315,205 | -321,361 | -247,287 | -319,169 |
| Reference price 2 | 21,101.54 | 20,285.85 | 23,504.27 | 20,512.82 | 21,367.52 | 20,512.82 |
| Nbr of stocks (in thousands) | 74,940 | 74,940 | 74,940 | 74,940 | 74,940 | 74,940 |
| Announcement Date | 15/03/21 | 07/03/22 | 15/03/23 | 22/03/24 | 27/03/25 | 23/03/26 |
1VND in Million2VND
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 57.01M | |
| 35.96x | 12.96x | 27.14x | 0.55% | 1,120B | |
| 37.4x | 6.3x | 17.74x | 2.09% | 616B | |
| 36.43x | 8.36x | 17.24x | 2.43% | 504B | |
| 20.46x | 4.99x | 12.38x | 2.64% | 367B | |
| 106.52x | 5.95x | 25.12x | 2.33% | 360B | |
| 21.18x | 5.54x | 13.63x | 2.88% | 288B | |
| 21.7x | 4.38x | 12.55x | 2.01% | 258B | |
| 27.46x | 7.06x | 12.64x | 2.33% | 234B | |
| -45.63x | 6.99x | 27.07x | 2.11% | 194B | |
| Average | 29.05x | 6.95x | 18.39x | 2.15% | 394.1B | |
| Weighted average by Cap. | 34.72x | 8.20x | 20.04x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OPC Stock
- Valuation OPC Pharmaceutical
Select your edition
All financial news and data tailored to specific country editions
